257 related articles for article (PubMed ID: 17162222)
41. Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension.
Wiest R; Jurzik L; Herold T; Straub RH; Schölmerich J
Peptides; 2007 Feb; 28(2):396-404. PubMed ID: 17194504
[TBL] [Abstract][Full Text] [Related]
42. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis.
Amitrano L; Guardascione MA; Ames PR
Clin Lab; 2007; 53(9-12):583-9. PubMed ID: 18257465
[TBL] [Abstract][Full Text] [Related]
43. [A clinical study on splanchnic hemodynamic changes after orthotopic liver transplantation for patients with portal hypertension].
Jiang SM; Zhou GW; Shen C; Yan JQ; Wan L; Li QY; Yang WP; Shen BY; Chen H; Peng CH; Li HW
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1699-702. PubMed ID: 19094727
[TBL] [Abstract][Full Text] [Related]
44. Arachidonic acid metabolites and endothelial dysfunction of portal hypertension.
Sacerdoti D; Pesce P; Di Pascoli M; Brocco S; Cecchetto L; Bolognesi M
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():80-90. PubMed ID: 26072731
[TBL] [Abstract][Full Text] [Related]
45. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
46. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
47. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
Heinemann A; Schuligoi R; Lippe IT; Stauber RE
Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
[TBL] [Abstract][Full Text] [Related]
48. Altered alpha adrenergic vasoresponsiveness in a non-cirrhotic portal hypertension model of E. coli injection.
Rizvi MR; Omanwar S; Fahim M; Sarin SK
J Gastroenterol Hepatol; 2007 Jun; 22(6):870-6. PubMed ID: 17565643
[TBL] [Abstract][Full Text] [Related]
49. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
50. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
[TBL] [Abstract][Full Text] [Related]
51. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
[TBL] [Abstract][Full Text] [Related]
52. Vascular liver disorders (II): portal vein thrombosis.
Hoekstra J; Janssen HL
Neth J Med; 2009 Feb; 67(2):46-53. PubMed ID: 19299846
[TBL] [Abstract][Full Text] [Related]
53. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
[TBL] [Abstract][Full Text] [Related]
54. Extrahepatic portal vein thrombosis.
Garcia-Pagán JC; Hernández-Guerra M; Bosch J
Semin Liver Dis; 2008 Aug; 28(3):282-92. PubMed ID: 18814081
[TBL] [Abstract][Full Text] [Related]
55. [Pathology of portal hypertension (author's transl)].
Tamayo RP
Rev Invest Clin; 1978; 30(1):29-34. PubMed ID: 635320
[No Abstract] [Full Text] [Related]
56. Decreased vascular reactivity of portal vein in rats with portal hypertension.
Huang YT; Lin HC; Yu PC; Lee FY; Tsai YT; Lee SD; Yang MC
J Hepatol; 1996 Feb; 24(2):194-9. PubMed ID: 8907573
[TBL] [Abstract][Full Text] [Related]
57. [Portal hypertension--introduction to the problem].
Brodanová M
Vnitr Lek; 1996 Oct; 42(10):696-9. PubMed ID: 8975461
[TBL] [Abstract][Full Text] [Related]
58. Cellular and molecular basis of portal hypertension.
Shah V
Clin Liver Dis; 2001 Aug; 5(3):629-44. PubMed ID: 11565134
[TBL] [Abstract][Full Text] [Related]
59. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
60. Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat.
Bexis S; McCormick PA; Docherty JR
Eur J Pharmacol; 2008 Aug; 590(1-3):322-6. PubMed ID: 18603238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
